Gauging the pharmaceutical burden on Sydney’s environment: a preventative response
暂无分享,去创建一个
[1] P. Barnes,et al. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial , 2002, European Respiratory Journal.
[2] C. Tzen,et al. Regulation of differentiation, proliferation and cancer suppressor activity. , 1993, The International journal of developmental biology.
[3] K. Kümmerer. Pharmaceuticals in the Environment , 2001 .
[4] John Jensen,et al. Veterinary Medicines and Soil Quality: The Danish Situation as an Example , 2001 .
[5] Christian G. Daughton,et al. Illicit Drugs in Municipal Sewage: Proposed New Nonintrusive Tool to Heighten Public Awareness of Societal Use of Illicit-Abused Drugs and Their Potential for Ecological Consequences , 2001 .
[6] John P. Sumpter,et al. Long-Term Temporal Changes in the Estrogenic Composition of Treated Sewage Effluent and Its Biological Effects on Fish , 2000 .
[7] K. Bjerve,et al. Omega 3 fatty acid deficiency in man: implications for the requirement of alpha-linolenic acid and long-chain omega 3 fatty acids. , 1991, World review of nutrition and dietetics.
[8] Alfredo C. Alder,et al. Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater , 1998 .
[9] Christian G. Daughton,et al. Pharmaceuticals and Care Products in the Environment: Scientific and Regulatory Issues , 2001 .
[10] Ettore Zuccato,et al. Environmental Loads and Detection of Pharmaceuticals in Italy , 2001 .
[11] W. H. Betts,et al. Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel , 1997, InflammoPharmacology.
[12] Ungemach Fr,et al. Figures on quantities of antibacterials used for different purposes in the EU countries and interpretation. , 2000 .
[13] G. Burr,et al. ON THE NATURE AND RÔLE OF THE FATTY ACIDS ESSENTIAL IN NUTRITION , 1930 .
[14] Thomas Ternes,et al. Pharmaceuticals and Metabolites as Contaminants of the Aquatic Environment , 2001 .